[Is the use of Fansidar as an antimalarial justified?].
D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D011739:Pyrimethamine / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine
Er det forsvarligt fortsat at anvende Fansidar til malariaforebyggelse?